New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
16:39 EDTCRM, TLYS, AET, ZLC, VVUS, STJ, SQNMOn The Fly: Closing Wrap
Stocks on Wall Street were higher on the day, the last full trading session of the week ahead of Thursday's holiday and Friday's half day. Jobless data that was in-line with expectations did little to move the markets before the open, but the markets slowly moved higher through the session, although volume remained light. Just after midday, news crossed that a cease fire between Israel and Hamas had been reached, tempering fears that the conflict could escalate to involve other players in the region and have broader economic impacts... ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 410,000, which was in-line with forecasts. Markit's "flash" November flash PMI rose to 52.4 from 51.0 in October. The final November reading of the University of Michigan Sentiment index slipped to 82.7 from its 84.9 preliminary reading. The leading indicators edged up 0.2% in October to 96.0 from 95.8 in September. In Europe, the region's finance ministers and the IMF were unable to reach a bailout agreement for Greece and will meet again on Monday with an eye on resolving the remaining disagreements. In Asia, Japanese exports fell 6.5% in October, lower than expectations for a 4.9% decline... COMPANY NEWS: Salesforce.com's (CRM) Q3 results beat on the top and bottom lines and RW Baird and Wells Fargo reiterated their Outperform ratings on the stock following the report, and shares of Salesforce.com traded higher on the session, settling up $12.88, or 8.83%, to $158.78... MAJOR MOVERS: Among notable gainers were shares of VIVUS (VVUS), up $1.38, or 13.33%, to $11.73 after Aetna (AET) posted a policy revision that expands coverage of the company's weight-loss drug Qsymia. Also higher were shares of Sequenom (SQNM), up 56c, or 15.18%, to $4.25 after a committee of the American College of Obstetricians and Gynecologists recommended that cell-free fetal DNA testing be offered to certain at-risk patients. Among the noteworthy were shares of Zale (ZLC), down over $2.23, or 29.97%, to $5.21, and Tilly's (TLYS), down $2.69, or 17.18%, to $12.97 after reporting earnings. Also lower were shares of St. Jude Medical (STJ), which fell $4.34, or 12.15%,to $31.37 after an FDA inspection report cited serious flaws in its oversight of design changes in its Durata line of defibrillator leads... INDICES The Dow was up 48.38, or 0.38%, to 12,836.89; the S&P 500 was up 3.22, or 0.23%, to 1,391.03;the Nasdaq was up 9.87, or 0.34%, to 2,926.55.
News For CRM;VVUS;AET;SQNM;ZLC;TLYS;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 19, 2014
16:07 EDTCRMSalesforce.com sees Q4 EPS 13c-14c, consensus 15c
Subscribe for More Information
16:06 EDTCRMSalesforce.com reports Q3 EPS 14c, consensus 13c
Subscribe for More Information
15:31 EDTCRMNotable companies reporting after market close
Subscribe for More Information
13:21 EDTCRMSalesforce.com November 61 straddle priced for 4.5% move into Q3
Subscribe for More Information
November 18, 2014
17:19 EDTSTJSt. Jude Medical: CHAMPION clinical trial shows reduction in readmission rates
Subscribe for More Information
13:36 EDTCRMSalesforce.com November volatility elevated into Q3 and outlook
Subscribe for More Information
11:40 EDTTLYSUrban Outfitters sinks to 52-week low after Q3 profit misses consensus
Subscribe for More Information
07:56 EDTCRMSalesforce.com remains a top large cap growth pick at BofA/Merrill
BofA/Merrill reiterates Salesforce.com as a top large cap growth pick for 2014 based on potential for accelerating operating income and TAM of $100B. Shares are Buy rated with a $73 price target.
November 17, 2014
07:16 EDTAETMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
16:26 EDTCRMNasdaq clear leader as major averages end week higher
Subscribe for More Information
November 13, 2014
12:03 EDTCRMBlackBerry announces agreement with Salesforce.com
Subscribe for More Information
08:24 EDTCRMSalesforce.com November volatility elevated into Q3 and outlook
Salesforce.com November call option implied volatility is at 50, December is at 38, January is at 33; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on November 19.
November 12, 2014
17:02 EDTCRMSalesforce.com signs agreement to purchase 50 Fremont Street building
Subscribe for More Information
08:58 EDTAETManaged Care earnings risk low from King vs. Burwell, says Leerink
Leerink believes the Supreme Court decision to the King vs. Burwell case carries low earnings risk for Managed Care companies. The case to determine the legality of Exchange subsidies administered by the Federal Government carries less than 2% and 3% of earnings risk for 2014 and 2015 estimates, respectively, Leerink believes. The firm says Humana (HUM) and Cigna (CI) are currently losing money on Exchanges, and thus could benefit from any Federal Exchange membership loss. Leerink lists Aetna (AET), Centene (CNC), WellPoint (WLP) and Molina Healthcare (MOH) as being most impacted.
08:02 EDTAETCredit Suisse to hold a conference
Subscribe for More Information
07:55 EDTAETAetna to reaffirm FY14 operating EPS view $6.60-$6.70, consensus $6.68
Subscribe for More Information
November 11, 2014
12:55 EDTAETWorkarounds to likely protect insurers from Supreme Court decision, says Wedbush
Subscribe for More Information
November 10, 2014
10:06 EDTAETAetna selected for new Louisiana Medicaid contract
Aetna Better Health of Louisiana, an Aetna health plan established to administer managed Medicaid services in Louisiana, has been selected by the State Department of Health & Hospitals to provide access to health care for eligible Louisianans. The three-year contract is scheduled to take effect Feb. 1, 2015.
08:46 EDTAETAetna price target raised to $99 from $90 at Jefferies
Jefferies raised its price target for Aetna shares to $99 after meeting with management and keeps a Buy rating on the stock. The firm believes Aetna's 2015 earnings growth can top the consensus of 10%.
07:54 EDTCRMChecks on Salesforce.com positive, says Oppenheimer
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use